Pingping Yang

597 total citations · 1 hit paper
33 papers, 402 citations indexed

About

Pingping Yang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Pingping Yang has authored 33 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Pingping Yang's work include Heart Failure Treatment and Management (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Hormonal Regulation and Hypertension (4 papers). Pingping Yang is often cited by papers focused on Heart Failure Treatment and Management (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Hormonal Regulation and Hypertension (4 papers). Pingping Yang collaborates with scholars based in China, United States and United Kingdom. Pingping Yang's co-authors include Gregory Y.H. Lip, Lifang Yang, Jun Ren, Qinghua Wu, Wen Shen, Gaosi Xu, Gaosi Xu, Jiru Zhang, Shuchun Yu and Siyuan Li and has published in prestigious journals such as Oncogene, Trends in Pharmacological Sciences and Frontiers in Immunology.

In The Last Decade

Pingping Yang

31 papers receiving 395 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Copper homeostasis and cuproptosis in cardiovascular disease therapeutics

2023 99 citations Lifang Yang, Pingping Yang et al. Trends in Pharmacological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pingping Yang China	11	144	94	93	74	56	33	402
Channa Zhang China	15	150 1.0×	192 2.0×	110 1.2×	45 0.6×	65 1.2×	38	609
Naoto Fujiwara Japan	11	187 1.3×	222 2.4×	125 1.3×	89 1.2×	90 1.6×	41	657
Shengqi Huo China	9	186 1.3×	52 0.6×	101 1.1×	69 0.9×	53 0.9×	17	396
Konstantinos Mourouzis Greece	12	214 1.5×	208 2.2×	88 0.9×	45 0.6×	46 0.8×	39	665
Patrick Crosswhite United States	8	123 0.9×	80 0.9×	206 2.2×	49 0.7×	23 0.4×	11	390
Masaaki Iwabayashi Japan	11	179 1.2×	100 1.1×	47 0.5×	44 0.6×	16 0.3×	24	442
Tao Xing China	12	247 1.7×	43 0.5×	101 1.1×	110 1.5×	26 0.5×	30	459
Zhongqi Yang China	14	313 2.2×	127 1.4×	134 1.4×	134 1.8×	21 0.4×	24	589
Hye Kyoung Sung Canada	12	190 1.3×	46 0.5×	63 0.7×	26 0.4×	57 1.0×	22	454

Countries citing papers authored by Pingping Yang

Since Specialization

Citations

This map shows the geographic impact of Pingping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingping Yang more than expected).

Fields of papers citing papers by Pingping Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pingping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingping Yang. The network helps show where Pingping Yang may publish in the future.

Co-authorship network of co-authors of Pingping Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Pingping Yang. A scholar is included among the top collaborators of Pingping Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pingping Yang. Pingping Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Deju, et al.. (2025). Role of Exosomes in Cardiovascular Disease: A Key Regulator of Intercellular Communication in Cardiomyocytes. ACS Omega. 10(18). 18145–18169. 1 indexed citations

Qi, Xin‐Rui, Lin Yang, Panpan Xia, et al.. (2025). Advances in anthocyanin nanoparticle delivery systems in anti-inflammatory therapies. Pharmacological Research. 222. 108038–108038.

Chen, Jiahui, et al.. (2024). PD-1 agonist: A novel therapeutic approach to resolve atherosclerosis. Results in Chemistry. 12. 101892–101892. 2 indexed citations

Yu, Wei, et al.. (2024). Chemokine Ligands and Receptors Regulate Macrophage Polarization in Atherosclerosis: A Comprehensive Database Mining Study. CJC Open. 7(3). 310–324. 1 indexed citations

Wang, Guangming, Wenjun Zhang, Jie Ren, et al.. (2024). The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia. Oncogene. 43(25). 1900–1916. 2 indexed citations

Yang, Pingping, et al.. (2023). Ideal serum non-ceruloplasmin bound copper prediction for long-term treated patients with Wilson disease: a nomogram model. Frontiers in Medicine. 10. 1275242–1275242. 1 indexed citations

Yang, Lifang, Pingping Yang, Gregory Y.H. Lip, & Jun Ren. (2023). Copper homeostasis and cuproptosis in cardiovascular disease therapeutics. Trends in Pharmacological Sciences. 44(9). 573–585. 99 indexed citations breakdown →

Shen, Wen, et al.. (2022). Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials. Frontiers in Cardiovascular Medicine. 9. 897423–897423. 2 indexed citations

Zhang, Jing, Xiaozhong Li, Yiwen Zhou, et al.. (2022). The Emerging Role of Noncoding RNA Regulation of the Ferroptosis in Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity. 2022(1). 3595745–3595745. 3 indexed citations

10.

Jiang, Yu, et al.. (2022). Comparative Cardiovascular Outcomes of SGLT2 Inhibitors in Type 2 Diabetes Mellitus: A Network Meta-Analysis of Randomized Controlled Trials. Frontiers in Endocrinology. 13. 802992–802992. 22 indexed citations

11.

Yang, Pingping, Qinghua Wu, Lizhe Sun, et al.. (2021). Adaptive Immune Response Signaling Is Suppressed in Ly6Chigh Monocyte but Upregulated in Monocyte Subsets of ApoE-/- Mice — Functional Implication in Atherosclerosis. Frontiers in Immunology. 12. 809208–809208. 8 indexed citations

12.

Pan, Mengmeng, Pingping Yang, Bing Li, et al.. (2021). Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma. Frontiers in Genetics. 12. 648800–648800. 5 indexed citations

13.

Yang, Pingping, Chenxi Wang, Shuai Yang, et al.. (2020). Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation. Cardiovascular Drugs and Therapy. 34(3). 371–381. 7 indexed citations

14.

Shen, Wen, Pingping Yang, Dan Zhu, et al.. (2020). Efficacy and Safety of Sacubitril-Valsartan in Heart Failure: A Meta-Analysis of Randomized Controlled Trials. ESC Heart Failure. 7(6). 3841–3850. 25 indexed citations

15.

Yang, Pingping, et al.. (2020). [Efficacy and safety of non-vitamin K antagonist versus vitamin K antagonist oral anticoagulants in the prevention and treatment of thrombotic disease in active cancer patients: a systematic review and meta-analysis of randomized controlled trials].. PubMed. 48(8). 689–696. 1 indexed citations

16.

Yang, Pingping, Dan Zhu, Wen Shen, et al.. (2019). Efficacy and safety of oral anticoagulants in atrial fibrillation patients with cancer—a network meta-analysis. Heart Failure Reviews. 25(5). 823–831. 13 indexed citations

17.

Yang, Pingping, Wen Shen, Xi Chen, et al.. (2019). Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials. Heart Failure Reviews. 24(5). 637–646. 21 indexed citations

18.

Yang, Pingping, et al.. (2018). Comparative Efficacy and Safety of Therapies in IgA Nephropathy: A Network Meta-analysis of Randomized Controlled Trials. Kidney International Reports. 3(4). 794–803. 11 indexed citations

19.

Yang, Pingping, Xi Chen, Lei Zeng, Hua Hao, & Gaosi Xu. (2017). The response of the Oxford classification to steroid in IgA nephropathy: a systematic review and meta-analysis. Oncotarget. 8(35). 59748–59756. 15 indexed citations

20.

Yang, Pingping, et al.. (2016). The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges. Metabolism. 65(9). 1342–1349. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact